About The Study: Oral corticosteroid use of more than 90 days per year among individuals with atopic dermatitis was associated with a small increased risk of composite adverse outcomes in this large population-based case-control study. Future investigations are warranted to confirm this potential risk of adverse events (AEs) associated with long-term use of oral corticosteroids for patients with exacerbations of atopic dermatitis, and health care professionals should thoroughly weigh the benefits associated with oral corticosteroids against the observed small risk of AEs, while continuously monitoring for AEs.
Corresponding Authors: To contact the corresponding authors, email Ju-Young Shin, Ph.D. ( shin.jy@skku.edu ) and Yang Won Lee, M.D., Ph.D. ( 20050078@kuh.ac.kr ).
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.23563)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.23563?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=071924
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
JAMA Network Open